GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

APL-2301   Click here for help

GtoPdb Ligand ID: 13957

Synonyms: ASN-1733 | MET-102
Compound class: Synthetic organic
Comment: APL-2301 is a nitroxoline derivative with broad-spectrum antibacterial activity [2]. It is being developed to target infections caused by Acinetobacter baumannii.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 75.73
Molecular weight 303.5
XLogP 2.99
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CN=C2C(=C1)C(=C(C(=C2O)[N+](=O)[O-])Br)Cl
Isomeric SMILES C1=CC2=C(C(=C(C(=C2Cl)Br)[N+](=O)[O-])O)N=C1
InChI InChI=1S/C9H4BrClN2O3/c10-5-6(11)4-2-1-3-12-7(4)9(14)8(5)13(15)16/h1-3,14H
InChI Key BZGYNSYRIWILNU-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
APL-2301 has approval in Australia for a first-in-human Phase 1 trial (last update December 2023) [1].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
APL-2301 has a dual mechanism of action [2]. It binds Ca2+ on the surface of bacteria, causing detachment of lipopolysaccharides (LPS) and thus disrupting the integrity of the bacterial outer membrane, leading to broad-spectrum bactericidal activity. APL-2301 also demonstrates potent inhibition of New Delhi metallo-β-lactamase-1 (NDM-1), via a novel competitive mechanism.